The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Lilly; Macrogenics; Novartis; Roche
Consulting or Advisory Role - Lilly; Novartis; Roche
Speakers' Bureau - Lilly; Novartis; Roche
Research Funding - AstraZeneca; Lilly; Macrogenics; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Lilly; Macrogenics; Novartis; Pfizer; Roche
SOPHIA primary analysis: A phase 3 (P3) study of margetuximab (M) + chemotherapy (C) versus trastuzumab (T) + C in patients (pts) with HER2+ metastatic (met) breast cancer (MBC) after prior anti-HER2 therapies (Tx).
 
Hope S. Rugo
Research Funding - Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology; Roche/Genentech; Sanofi
 
Seock-Ah Im
Consulting or Advisory Role - AstraZeneca; Eisai; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - MSD Oncology; Novartis; Roche/Genentech
Other Relationship - Roche
 
Gail Lynn Shaw Wright
Stock and Other Ownership Interests - Odonate Therapeutics; Puma Biotechnology; Roche
 
Santiago Escriva-de-Romani
Consulting or Advisory Role - Pierre Fabre; Roche
Speakers' Bureau - Celgene; Eisai; Kyowa Hakko Kirin; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Daiichi Sankyo; Pierre Fabre; Roche
 
Michelino DeLaurentiis
Honoraria - Amgen; Celgene; Eisai; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Celgene; Eisai; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; Celgene; Eisai; Lilly; Novartis; Pfizer; Roche
Research Funding - Eisai; Roche
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche; Samsung
Consulting or Advisory Role - AstraZeneca; Biothera; Celgene; Cellestia Biotech; Daiichi Sankyo; ERYTECH Pharma; Merus; Polyphor; Roche; Seagen
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Baxalta (Inst); Bayer (Inst); Eisai (Inst); Guardant Health (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Pique (Inst); Puma Biotechnology (Inst); Queen Mary university of London (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Eisai; Novartis; Pfizer; Roche
 
Shakeela Wazeen Bahadur
Travel, Accommodations, Expenses - Macrogenics
 
Barbara B. Haley
Research Funding - GlaxoSmithKline; Lilly; Puma Biotechnology; Roche
 
Raul H. Oyola
Research Funding - BMS Brazil; Roche
 
David A. Riseberg
Consulting or Advisory Role - Agendia; Bayer; Celgene; Impact Biomedicines
Speakers' Bureau - Novartis; Puma Biotechnology
Research Funding - Agendia; Amgen; Daiichi Sankyo; Evidera; Genentech; Helsinn Healthcare; Macrogenics; Merck; Novartis; Pfizer; Puma Biotechnology; Roche; TG Therapeutics
 
Antonino Musolino
No Relationships to Disclose
 
Fatima Cardoso
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; GE Healthcare; Genentech; GlaxoSmithKline; Macrogenics; Merck Sharp & Dohme; Merus; Mundipharma; Mylan; Novartis; Pfizer; Pierre Fabre; Roche; Samsung Bioepis; Sanofi; Seagen; Teva
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Giuseppe Curigliano
Honoraria - Ellipses Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Speakers' Bureau - Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Peter A. Kaufman
Stock and Other Ownership Interests - Amgen
Consulting or Advisory Role - Eisai; Lilly; Macrogenics; Polyphor; Roche/Genentech
Speakers' Bureau - Lilly; Teva
Research Funding - Eisai (Inst); Lilly (Inst); Macrogenics (Inst); Novartis (Inst); Polyphor (Inst); Roche/Genentech (Inst)
 
Mark D. Pegram
Employment - Loxo (I)
Honoraria - See consulting below
Consulting or Advisory Role - Daiichi Sankyo; Genentech/Roche; Macrogenics; Seagen
 
Sutton Edlich
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Sam Hong
Employment - Macrogenics
 
Edwin P. Rock
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
William John Gradishar
Consulting or Advisory Role - Genentech/Roche